Physician profile
Curtis Elam
NPI 1184693558
$668.17
in general payments reported to CMS, 2019-2025
14 companies · $71.03 in 2025
The $71.03 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.16 · 2020: $26.88 · 2021: $137 · 2022: $167 · 2023: $13.55 · 2024: $170 · 2025: $71.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $269.75 | 2019-2024 | |
| Organon LLC | $89.05 | 2021-2025 | Nexplanon |
| Conmed Corporation | $61.01 | 2022 | |
| Hologic Sales and Service, LLC | $43.64 | 2020-2022 | |
| Davol INC. | $40.34 | 2025 | Arista |
| Smith+Nephew, INC. | $30.00 | 2024 | Pico |
| Pfizer INC. | $24.86 | 2024 | |
| Abbvie INC. | $18.62 | 2021 | |
| Optumhealth Care Solutions, LLC | $16.33 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Coopersurgical, INC. | $15.79 | 2022 | |
| Boston Scientific Corporation | $15.46 | 2022 | |
| Innovation Technologies INC | $14.97 | 2025 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $14.75 | 2020 | |
| Astellas Pharma US INC | $13.60 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Elam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.